Clinical evaluation of emergency liver transplantation for patients with benign end-stage liver diseases

National Medical Journal of China

Volumn 85, Issue 49, 2005, Pages 3460-3463

  Wang, Wei Lin ^a   Zheng, Shu Sen ^a   Xu, Xiao ^a   Liang, Ting Bo ^a   Jin, Jing ^a   Shen, Yan ^a   Zhang, Min ^a   Wu, Jian ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Benign end stage liver disease; CTP; Liver transplantation; MELD

Indexed keywords

ALBUMIN; BILIRUBIN; CREATININE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; EMERGENCY HEALTH SERVICE; FEMALE; GRAFT SURVIVAL; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PREDICTION; PROGNOSIS; RECIPIENT; RETROSPECTIVE STUDY; SALVAGE THERAPY; SCORING SYSTEM; SURVIVAL RATE;

ADULT; CREATININE; EMERGENCIES; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 30444461190     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Wu J, Zheng SS. The donor liver allocation system: a model for end-stage liver disease. Hepatobiliary Pancreat Dis Int, 2004, 3: 330-331.
2. Salerno F, Merli M, Gazzaniga M, et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol, 2002, 36: 494-500.
3. Bjoro K, Kirkegaard P, Ericzon BG, et al. Is a 3-Day Limit for Highly Urgent Liver Transplantation for Fulminant Hepatic Failure Appropriate, and Is the Diagnosis in Some Cases Incorrect? Transplant Proc, 2001, 33: 2511-2513.
4. Zieniewicz K, Skwarek A, Nyckowski P, et al. Comparison of the Results of Liver Transplantation for Elective Versus Urgent Indications. Transplant Proc, 2003, 35: 2262-2264.
5. Gonzalez E, Rimola A, Navasa M, et al. Liver transplantation in patients with non-biliary cirrhosis: prognostic value of preoperative factors. J Hepatol, 1998, 28: 320-328.
6. Ricci GL. Choice and costs of liver transplantation. Recenti Prog Med, 1997, 88: 592-593.
7. Baliga P, Merion RM, Turcotte JG, et al. Preoperative risk factor assessment in liver transplantation. Surgery, 1992, 112: 704-710.
8. Gunning TC, Brown MR, Swygert TH, et al. Perioperative renal function in patients undergoing orthotopic liver transplantation. A randomized trial of the effects of verapamil. Transplantation, 1991, 51: 422-427.
9. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology, 2001, 33: 464-470.